Latest Breaking News On - Tom riga - Page 1 : vimarsana.com

Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update

– ONC201 ACTION Study Progressing; Reiterate Interim OS Data Expected in 2025, Final OS Data Expected in 2026 –

United statesLisa deckerPablo leeMike andrioleAmerican society of clinical oncologyNational institutes of healthOncology consortiumExchange commissionReiterate interimPeer reviewed journalClinical oncologyConference callChief executive officerMichelle laspalutoChief financial officerTom riga

Chimerix Reports Fourth Quarter And Year End 2023 Financial Results And Provides Operational Update

Chimerix Reports Fourth Quarter And Year End 2023 Financial Results And Provides Operational Update
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesMike andrioleLisa deckerPablo leeNational institutes of healthAmerican society of clinical oncologyOncology consortiumExchange commissionReiterate interimPeer reviewed journalClinical oncologyConference callChief executive officerMichelle laspalutoChief financial officerTom riga

Assertio Holdings, Inc (NASDAQ:ASRT) Q2 2023 Earnings Call Transcript

Operator: Good morning, and welcome to the Assertio Holdings Inc Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in -a listen-only mode.

Hamed khorsandMatt krepsThomas flatenScott henryRoman khorsandJim sidotiMayank mamtaniDan peisertPaul schwichtenbergCommunity oncologyAssertio therapeutics incDarrow associatesAssertio holdings incSpectrum pharmaceuticalsSymphony healthAssertio holdings inc second quarter

Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update

Q1 2023 net sales of $15.6 million, an increase of 54% compared to Q4 2022 Company to be acquired by Assertio Holdings, Inc., delivering value to stakeholders in an all stock and. | May 9, 2023

Securities exchangeAssertio holdings incSpectrum investor relations departmentSpectrum pharmaceuticalsNuclear imagingAssertio investor relations departmentSpectrum pharmaceuticals incRecent businessAssertio holdingsTom rigaChief executive officerQuarter ended marchContinuing operationsRespiratory distress syndromeCell crisisSickle cell

Assertio Therapeutics (ASRT) to Acquire Spectrum Pharmaceuticals (SPPI) in Stock and CVR Deal

Assertio Therapeutics (ASRT) to Acquire Spectrum Pharmaceuticals (SPPI) in Stock and CVR Deal
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Dan peisertLisa wilsoninContactsnora brennanMatt krepsdarrow associatesExchange commissionAssertio holdings incGuggenheim securitiesSpectrum pharmaceuticalsSite communications incNuclear imagingHc wainwright coDunn crutcherInvestor relations at assertio holdings incSpectrum pharmaceuticals incLatham watkinsChief executive officer